Humed Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2016
About Humed Medicines
Humed Medicines Private Limited (HMPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2016 (Eight years and 11 months 6 days old ). Its registered office is in Delhi, India.
The Corporate was formerly known as Cobad Foods And Beverages Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Pathak, Kiran Pathak, Geetesh Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15122DL2016PTC291771
-
Company No.
291771
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Feb 2016
-
Date of AGM
30 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Humed Medicines?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Pathak
|
Director | 09-Mar-2016 | Current |
|
Kiran Pathak
|
Director | 09-Mar-2016 | Current |
|
Geetesh Singh
|
Director | 09-Mar-2016 | Current |
|
Abhishek Singh
|
Director | 09-Mar-2016 | Current |
Financial Performance of Humed Medicines.
Enhance accessibility to Humed Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Humed Medicines?
In 2016, Humed Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ulticure Biolabs Private LimitedJitendra Pathak and Kiran Pathak are mutual person
-
Rajsi Services Private Limited
Jitendra Pathak and Kiran Pathak are mutual person
-
Radhey Rani Services Private Limited
Jitendra Pathak and Kiran Pathak are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Humed Medicines?
Unlock and access historical data on people associated with Humed Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Humed Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humed Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
